Form 4 for RNAC Cartesian Therapeutics, Inc.
Accepted 2024-07-03 00:00:00 ET · period of report 2024-07-01 · accession 0001453687-24-000093 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-03 | 2024-07-01 | RNAC | Malik Kemal | Dir | A - Grant | $0.00 | +5,933 | 5,933 | New | $0 |
| D | 2024-07-03 | 2024-07-01 | RNAC | Malik Kemal | Dir | A - Grant | $0.00 | +7,600 | 7,600 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-01 | A | A | 5,933 | $0.00 | 5,933 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-07-01 | A | A | 7,600 | $0.00 | 7,600 | D | $24.27 · — to 2034-06-30 | 7,600 Common Stock | (F2) This award will vest in 36 equal monthly installments, so that it shall be fully vested on July 1, 2027. |